1. 1. US Food and Drug Administration. Pharmaceutical quality for the 21st century a risk-based approach progress report. Published May, 2007. Accessed October 4, 2023. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/pharmaceutical-quality-21st-century-risk-based-approach-progress-report.
2. 2. Clinical Trials Transformation Initiative. Quality by design. Accessed October 4, 2023. https://ctti-clinicaltrials.org/our-work/quality/quality-by-design/.
3. 3. US Food and Drug Administration. FDA oversight of clinical investigations — a risk-based approach to monitoring. Published August, 2013. Accessed October 4, 2023. https://www.fda.gov/media/116754/download.
4. 4. European Medicines Agency. Reflection paper on risk-based quality management in clinical trials. Published November 18, 2013. Accessed October 4, 2023. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-risk-based-quality-management-clinical-trials_en.pdf.
5. 5. TransCelerate Biopharma Inc. Position paper: risk-based monitoring methodology. Accessed October 4, 2023. http://www.transceleratebiopharmainc.com/assets/risk-based-monitoring/.